TCM-Guided Targeted Therapies Against NLRP3 Inflammasome in NAFLD
{{output}}
Background: Non-alcoholic fatty liver disease (NAFLD) is a prevalent metabolic disorder driven by inflammation, in which the NLRP3 inflammasome plays a central role. Current targeted inhibitors face challenges in patient stratifi... ...
